5亿大健康基金落地:天津发展附属公司认缴1.74亿,泰达系+建行系共投

财中社
Sep 10, 2025

  天津发展(00882)发布公告,2025年9月10日,公司间接非全资附属公司力生制药与建信股权、泰达私募、共青城建兴、泰达国际、国资母基金及战新基金订立合伙协议,设立基金,认缴出资总额为5亿元。

  其中,力生制药作为有限合伙人,已向该基金认缴出资1.74亿元,约占该基金认缴出资总额的34.75%。

  泰达控股通过其附属公司间接持有公司约62.81%的股份,为公司的控股股东及关联方。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10